Cerebrospinal fluid (CSF) management involves the use of devices such as shunts and external drainage systems to maintain the flow of CSF and drain excess fluid from the brain. Over the years, the disease burden of hydrocephalus has increased considerably, increasing the demand for CSF management devices as a method of treatment. The growing healthcare market in developing economies is also expected to provide growth opportunities for players in the market. On the other hand, the dearth of trained professionals and complications related to CSF shunts may challenge market growth to a certain extent.
How much is the Cerebrospinal Fluid Management Market worth?
The Cerebrospinal Fluid Management Market is projected to reach USD 1,561.1 million by 2022 from an estimated USD 1,256.3 million in 2017, at a CAGR of 4.4%. The high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population are major factors driving the market growth. North America is expected to register the highest growth rate during the forecast period.
Shunts to dominate the cerebrospinal fluid (CSF) management market in 2017
The large market share of this product segment can be attributed to the growing number of shunting procedures performed worldwide as well as the increasing number of revisions shunt surgeries owing to shunt malfunction and infection.
Ventriculoperitoneal segment dominated the CSF shunts market in 2017
On the basis of type, the shunts market is segmented into ventriculoperitoneal (VP), ventriculoatrial (VA), ventriculopleural (VPL), and lumboperitoneal (LP) shunts. This segment is also estimated to register the highest CAGR during the forecast period. Factors propelling the growth of this segment include the advantages associated with these shunts over other shunts, such as reduced chances of revision surgery and the lower average length of hospital stay.
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160672575
Adjustable valve shunts accounted for the largest share of the CSF shunts market in 2017
On the basis of valve type, the shunts market is categorized into fixed and adjustable. The adjustable segment commanded the largest share of the shunts market in 2017 and is also estimated to register the highest CAGR during the forecast period. The major factor contributing to the growth of this market segment is the reduced intervention for the alteration of CSF flow along with their rising adoption in developed countries.
External ventricular drainage to command the largest share of external drainage systems market in 2017
On the basis of type, the external drainage systems market is categorized into external ventricular drainage (EVD) systems and lumbar drainage (LD) systems. The external ventricular drainage systems segment commanded the largest share of the external drainage systems market in 2017 and is also estimated to register the highest CAGR of during the forecast period. This can be attributed to its growing application for the treatment of acute hydrocephalus and obstructive hydrocephalus.
Pediatric end-user segment dominated the cerebrospinal fluid management market in 2017
On the basis of end-users, the market is categorized into pediatric, adult, and geriatric end users. The pediatric segment commanded the largest share of the cerebrospinal fluid (CSF) management market in 2017 and is also estimated to register the highest CAGR during the forecast period. This can be attributed to the high prevalence of congenital hydrocephalus along with the rising number of shunting procedures in the pediatric population.
Request for Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=160672575
North America is expected to dominate the cerebrospinal fluid management market in 2018.
This report covers the market across four major geographies, namely, North America, Europe, AsiaPacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to register the highest growth rate during the forecast period.
Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to command the largest share of the market in 2018. The large share of North America in the global occlusion devices market is attributed to the increasing availability of medical reimbursements for cardiovascular procedures, increasing patient preference for minimally invasive surgical procedures (including occlusion treatment), and strong market presence of key OEMs (that replicates into the easy availability of occlusion devices).
Leading Companies
The major players in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US).
For More Information @ https://www.marketsandmarkets.com/PressReleases/occlusion-device.asp